Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 3

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Longitudinal associations of cumulative and repeated-measure patterns of insulin resistance surrogate indices with biological age acceleration and incident cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0–3: evidence from CHARLS 2011–2020

Han, Shu-Shu, Liu, Qin, Zhou, Min-Qi, Liu, Yun, Guo, Ting-Ting, Hu, Yue-Kang, Gao, Teng-Ao, Zeng, Zhi-Ming·2026·Cardiovascular Diabetology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-026-03206-z

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 71

  1. Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J. 2011;75(12):2739–48. · DOI · Paper page
  2. Matsushita K, Ballew SH, Wang AY, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18(11):696–707. · DOI · Paper page
  3. Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636–64. · DOI · Paper page
  4. Kadowaki T, Maegawa H, Watada H, Yabe D, Node K, Murohara T, et al. Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan. Diabetes Obes Metab. 2022;24(12):2283–96. · DOI · Paper page
  5. Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011–2020. JAMA. 2024;331(21):1858–60. · DOI · Paper page
  6. Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245–50. · DOI · Paper page
  7. Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575–85. · DOI · Paper page
  8. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. · DOI · Paper page
  9. Tian X, Chen S, Xu Q, Xia X, Zhang Y, Wang P, et al. Magnitude and time course of insulin resistance accumulation with the risk of cardiovascular disease: an 11-years cohort study. Cardiovasc Diabetol. 2023;22(1):339. · DOI
  10. Jing J, Pan Y, Zhao X, Zheng H, Jia Q, Mi D, et al. Insulin resistance and prognosis of nondiabetic patients with ischemic stroke: the ACROSS-China study (Abnormal glucose regulation in patients with acute stroke across China). Stroke. 2017;48(4):887–93. · DOI
  11. Chang Y, Kim CK, Kim MK, Seo WK, Oh K. Insulin resistance is associated with poor functional outcome after acute ischemic stroke in non-diabetic patients. Sci Rep. 2021;11(1):1229. · DOI
  12. Ago T, Matsuo R, Hata J, Wakisaka Y, Kuroda J, Kitazono T, et al. Insulin resistance and clinical outcomes after acute ischemic stroke. Neurology. 2018;90(17):e1470–7. · DOI
  13. Yao F, Cui J, Shen Y, Jiang Y, Li Y, Liu X, et al. Evaluating a new obesity indicator for stroke risk prediction: comparative cohort analysis in rural settings of two nations. BMC Public Health. 2024;24(1):3301. · DOI
  14. Ou H, Wei M, Li X, Xia X. C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):296. · DOI
  15. Han SS, Liu Q, Zeng ZM, Li Y, Li PW, Cheng FX, et al. Association of various insulin resistance surrogate indices with aging acceleration and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: insights from CHARLS 2011-2020 data. Cardiovasc Diabetol. 2026. https://doi.org/10.1186/s12933-026-03084-5. · DOI
  16. Wang C, He S, Xie G, Zhang S, Xiong Z, Lu H, et al. Associations of longitudinal trajectories of triglyceride-glucose index combined with classical and novel obesity indices and cardiovascular disease: evidence from a nationwide prospective cohort study in China. Cardiovasc Diabetol. 2025;24(1):431. · DOI
  17. Janssen J. Hyperinsulinemia and its pivotal role in aging, obesity, type 2 diabetes, cardiovascular disease and cancer. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22157797. · DOI · Paper page
  18. Tan MY, Jiang ZN, Li YQ, Li ZY, Niu B. Association of estimated glucose disposition rate with aging acceleration and mortality risk in individuals with cardiovascular-kidney-metabolic syndrome: evidence from two large national population-based studies. Cardiovasc Diabetol. 2025;24(1):402. · DOI
  19. Hägg S, Belsky DW, Cohen AA. Developments in molecular epidemiology of aging. Emerg Top Life Sci. 2019;3(4):411–21. · DOI
  20. Guerville F, De Souto Barreto P, Ader I, Andrieu S, Casteilla L, Dray C, et al. Revisiting the hallmarks of aging to identify markers of biological age. J Prev Alzheimers Dis. 2020;7(1):56–64. · DOI
  21. Hao M, Zhang H, Wu J, Huang Y, Li X, Wang M, et al. Gompertz law-based biological age (GOLD BioAge): a simple and practical measurement of biological ageing to capture morbidity and mortality risks. Adv Sci. 2025;12(32):e01765. · DOI
  22. Klemera P, Doubal S. A new approach to the concept and computation of biological age. Mech Ageing Dev. 2006;127(3):240–8. · DOI · Paper page
  23. Li X, Wang J, Zhang M, Li X, Fan Y, Zhou X, et al. Biological aging mediates the associations of metabolic score for insulin resistance with all-cause and cardiovascular disease mortality among US adults: a nationwide cohort study. Diabetes Obes Metab. 2024;26(9):3552–64. · DOI
  24. Liu N, Peng S, Wei K, Chen Q, Chen X, He L, et al. Association between cardiometabolic index and biological ageing among adults: a population-based study. BMC Public Health. 2025;25(1):879. · DOI
  25. Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–8. · DOI · Paper page
  26. Chen X, Crimmins E, Hu PP, Kim JK, Meng Q, Strauss J, et al. Venous blood-based biomarkers in the China Health and Retirement Longitudinal Study: rationale, design, and results from the 2015 wave. Am J Epidemiol. 2019;188(11):1871–7. · doi:10.1093/aje/kwz170
  27. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44. · DOI · Paper page
  28. He HM, Xie YY, Chen Q, Li YK, Li XX, Mu YK, et al. The additive effect of the triglyceride-glucose index and estimated glucose disposal rate on long-term mortality among individuals with and without diabetes: a population-based study. Cardiovasc Diabetol. 2024;23(1):307. · DOI
  29. He HM, Xie YY, Chen Q, Li YK, Li XX, Fu SJ, et al. The synergistic effect of the triglyceride-glucose index and a body shape index on cardiovascular mortality: the construction of a novel cardiovascular risk marker. Cardiovasc Diabetol. 2025;24(1):69. · DOI
  30. Ruan GT, Xie HL, Zhang HY, Liu CA, Ge YZ, Zhang Q, et al. A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer. Front Endocrinol (Lausanne). 2022;13:905266. · DOI · Paper page
  31. Zabala A, Darsalia V, Lind M, Svensson AM, Franzén S, Eliasson B, et al. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study. Cardiovasc Diabetol. 2021;20(1):202. · DOI · Paper page
  32. Zou Y, Lu S, Li D, Huang X, Wang C, Xie G, et al. Exposure of cumulative atherogenic index of plasma and the development of prediabetes in middle-aged and elderly individuals: evidence from the CHARLS cohort study. Cardiovasc Diabetol. 2024;23(1):355. · DOI
  33. Lu L, Chen Y, Liu B, Li X, Wang J, Nie Z, et al. Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):202. · DOI
  34. Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):292. · DOI · Paper page
  35. He D, Wang Z, Li J, Yu K, He Y, He X, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J. 2024;45(12):1058–68. · DOI · Paper page
  36. Gao K, Cao LF, Ma WZ, Gao YJ, Luo MS, Zhu J, et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China Health and Retirement Longitudinal Study. EClinicalMedicine. 2022;44:101264. · DOI · Paper page
  37. Cui C, Liu L, Zhang T, Fang L, Mo Z, Qi Y, et al. Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2023;22(1):325. · DOI
  38. Chen L, Zhang Y, Yu C, Guo Y, Sun D, Pang Y, et al. Modeling biological age using blood biomarkers and physical measurements in Chinese adults. EBioMedicine. 2023;89:104458. · DOI
  39. Liu Z. Development and validation of 2 composite aging measures using routine clinical biomarkers in the Chinese population: analyses from 2 prospective cohort studies. J Gerontol A Biol Sci Med Sci. 2021;76(9):1627–32. · DOI
  40. Xiang Y, Xu H, Chen H, Tang D, Huang Z, Zhang Y, et al. Tea consumption and attenuation of biological aging: a longitudinal analysis from two cohort studies. Lancet Reg Health West Pac. 2024;42:100955.
  41. Pan R, Wang J, Chang WW, Song J, Yi W, Zhao F, et al. Association of PM2.5 components with acceleration of aging: moderating role of sex hormones. Environ Sci Technol. 2023;57(9):3772–82. · DOI
  42. Sinaga KP, Yang M-S. Unsupervised K-means clustering algorithm. IEEE Access. 2020;8:80716–27. · DOI · Paper page
  43. Keil AP, Buckley JP, O’Brien KM, Ferguson KK, Zhao S, White AJ. A quantile-based g-computation approach to addressing the effects of exposure mixtures. Environ Health Perspect. 2020;128(4):47004. · DOI · Paper page
  44. Tanner EM, Bornehag CG, Gennings C. Repeated holdout validation for weighted quantile sum regression. MethodsX. 2019;6:2855–60. · DOI · Paper page
  45. Zhang X, Stamey JD, Mathur MB. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence. Pharmacoepidemiol Drug Saf. 2020;29(10):1219–27. · DOI
  46. Sjölander A, Greenland S. Are E-values too optimistic or too pessimistic? Both and neither! Int J Epidemiol. 2022;51(2):355–63. · DOI
  47. Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0–3: a cohort study. Cardiovasc Diabetol. 2025;24(1):92. · DOI
  48. Zhang R, Hong J, Wu Y, Lin L, Chen S, Xiao Y. Joint association of triglyceride glucose index (TyG) and a body shape index (ABSI) with stroke incidence: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):7. · DOI
  49. Wang M, Gao B, Huang F. Association between the triglyceride glucose-Chinese visceral adiposity index and new-onset stroke risk: a national cohort study. Cardiovasc Diabetol. 2025;24(1):119. · DOI
  50. Dong B, Chen Y, Yang X, Chen Z, Zhang H, Gao Y, et al. Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in Cardiovascular-Kidney-Metabolic Syndrome stages 0–3 and the development of a machine learning prediction model: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):163. · DOI
  51. Yang Y, Liu A. Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident stroke in middle-aged and older Chinese adults: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):386. · DOI
  52. Zheng G, Jin J, Wang F, Zheng Q, Shao J, Yao J, et al. Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):22. · DOI
  53. Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y, et al. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):254. · DOI
  54. Wang Y, Wei N, Li M, Liu JW, Lin HB, Zhang HF. Cumulative exposure to the estimated glucose disposal rate and incident stroke in individuals with cardiovascular-kidney-metabolic syndrome stages 0-4: 6-year longitudinal evidence from CHARLS. Cardiovasc Diabetol. 2026. https://doi.org/10.1186/s12933-026-03096-1. · doi:10.1186/s12933-026-03096-1
  55. Worthley MI, Holmes AS, Willoughby SR, Kucia AM, Heresztyn T, Stewart S, et al. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration. J Am Coll Cardiol. 2007;49(3):304–10. · DOI · Paper page
  56. Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, Rifai N, et al. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J. 2007;28(7):806–13. · DOI
  57. Molina MN, Ferder L, Manucha W. Emerging role of nitric oxide and heat shock proteins in insulin resistance. Curr Hypertens Rep. 2016;18(1):1. · DOI · Paper page
  58. Peng J, Luo F, Ruan G, Peng R, Li X. Hypertriglyceridemia and atherosclerosis. Lipids Health Dis. 2017;16(1):233. · DOI · Paper page
  59. Akivis Y, Alkaissi H, McFarlane SI, Bukharovich I. The role of triglycerides in atherosclerosis: recent pathophysiologic insights and therapeutic implications. Curr Cardiol Rev. 2024;20(2):39–49. · DOI
  60. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–7. · DOI · Paper page
  61. Faro DC, Di Pino FL, Monte IP. Inflammation, oxidative stress, and endothelial dysfunction in the pathogenesis of vascular damage: unraveling novel cardiovascular risk factors in Fabry disease. Int J Mol Sci. 2024. https://doi.org/10.3390/ijms25158273. · DOI
  62. Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107. · DOI · Paper page
  63. Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol. 2012;32(8):1754–9. · DOI · Paper page
  64. Kellar D, Craft S. Brain insulin resistance in Alzheimer’s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 2020;19(9):758–66. · DOI · Paper page
  65. Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016;311(6):F1087-f1108. · DOI · Paper page
  66. Greer EL, Brunet A. FOXO transcription factors in ageing and cancer. Acta Physiol (Oxf). 2008;192(1):19–28. · DOI · Paper page
  67. Monickaraj F, Aravind S, Gokulakrishnan K, Sathishkumar C, Prabu P, Prabu D, et al. Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol Cell Biochem. 2012;365(1–2):343–50. · DOI
  68. Brie AD, Christodorescu RM, Popescu R, Adam O, Tîrziu A, Brie DM. Atherosclerosis and insulin resistance: Is there a link between them? Biomedicines. 2025. https://doi.org/10.3390/biomedicines13061291. · DOI
  69. Ruiz-García A, Serrano-Cumplido A, Escobar-Cervantes C, Arranz-Martínez E, Pallarés-Carratalá V. Prevalence rates of abdominal obesity, high waist-to-height ratio and excess adiposity, and their associated cardio-kidney-metabolic factors: SIMETAP-AO study. Nutrients. 2024. https://doi.org/10.3390/nu16223948. · DOI
  70. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380(9841):601–10. · DOI · Paper page
  71. Sabanayagam C, He F, Chee ML, Cheng CY. Validity and reliability of self-reported prevalent and incident cardiovascular disease among Asian adults. J Cardiovasc Dev Dis. 2024. https://doi.org/10.3390/jcdd11110350. · doi:10.3390/jcdd11110350

Metadata

Authors
Han, S.-S., Liu, Q., Zhou, M.-Q., Liu, Y., Guo, T.-T., Hu, Y.-K., Gao, T.-A., & Zeng, Z.-M.
Venue
Cardiovascular Diabetology
Published
2026-05-16
Volume
25
Issue
1
ISSN
1475-2840
Cited by
3
References
9
Language
en
Licence
Funders
  • Shenzhen High-level Hospital Construction Fund
  • Youth Program of National Natural Science Foundation of China (62201015)
  • Clinical Medicine Plus X-Young Scholars Project, Peking University, the Fundamental Research Funds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Longitudinal associations of cumulative and repeated-measure patterns of insulin resistance surrogate indices with biological age acceleration and incident cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0–3: evidence from CHARLS 2011–2020. https://app.cochat.ai/papers/10.1186/s12933-026-03206-z
The paper
Han, S.-S., Liu, Q., Zhou, M.-Q., Liu, Y., Guo, T.-T., Hu, Y.-K., Gao, T.-A., & Zeng, Z.-M. (2026). Longitudinal associations of cumulative and repeated-measure patterns of insulin resistance surrogate indices with biological age acceleration and incident cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0–3: evidence from CHARLS 2011–2020. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-026-03206-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.